Andrew Lacy

Andrew Lacy

Partner Co-Chair, Antitrust + Competition
Andrew Lacy

Andrew Lacy is a co-chair of Goodwin’s Antitrust and Competition practice and a member of the firm’s Life Sciences Disputes group. He advises clients on transaction-related antitrust risk, negotiating terms of agreements, and determining the applicability of merger clearance filing requirements in both U.S. and foreign jurisdictions. He represents clients before the FTC, DOJ, and state regulators in connection with informal inquiries, Second Requests, conduct investigations, and third-party subpoenas. Mr. Lacy has represented clients in merger challenges, class actions and other private antitrust litigation matters. He also provides guidance on antitrust issues related to diligence and pre-closing conduct procedures, internal compliance programs, hiring and non-compete agreements, vendor agreements, and competitor collaboration guidelines.





Mr. Lacy’s recent representative experience includes:

  • Citrix Systems in its definitive agreement under which affiliates of Vista Equity Partners, and Evergreen Coast Capital Corporation, an affiliate of Elliott Investment Management L.P., will acquire Citrix for $16.5 billion
  • Bio Products Laboratory (BPL) and its shareholder, Tiancheng International Investment Limited, in their agreement for BPL to be jointly acquired and combined with Kedrion Biopharma by funds advised by Permira Capital Partners, who have entered into a partnership with Kedrion’s existing shareholders
  • Limelight Networks in its definitive agreement to acquire Yahoo's Edgecast for $300 million
  • PointClickCare Technologies on its proposed acquisition of Audacious Inquiry 
  • Mimecast Limited in its definitive agreement to be acquired by Permira for approximately $5.8 billion
  • TA Associates Management, L.P. in the sale of its portfolio company, PLS Holdings, LLC to Bentley Systems, Incorporated for approximately $700 million
  • Lime Rock New Energy, L.P. in its acquisition of Electric Power Engineers, Inc.
  • CSafe Global, a portfolio company of Frazier Healthcare Partners and Thomas H. Lee Partners, in its acquisition of Softbox Systems 
  • Argos Health in its merger with EnableComp
  • Lucid Holdings in its acquisition by Cint Group AB for $1.1 billion
  • Nimbus Therapeutics in its proposed acquisition by Celgene and Nimbus's related antitrust litigation against Celgene and Bristol Myers Squibb 
  • Tiancheng International Investment Ltd in its proposed sale of Biotest to Grifols for EUR 1.1 billion
  • Trillium Therapeutics in its sale to Pfizer for $2.26 billion
  • Innovium in its acquisition by Marvell Technology for $1.1 billion 
  • RBC Bearings Incorporated in its acquisition of the DODGE mechanical power transmission division of Asea Brown Boveri Ltd for $2.9 billion
  • Synaptics Incorporated in its acquisition of DSP Group
  • Oculii Corporation in its acquisition by Ambarella
  • Waste Management in its proposed acquisition of Advanced Disposal*
  • Waystar in its acquisition of eSolutions, a leading provider of healthcare revenue cycle and Medicare analytics*
  • Gardner Denver in its acquisition of Ingersoll-Rand’s industrials business*
  • BMW Group and Daimler AG in FTC clearance of their joint venture in mobility services*
  • HCA in its defeat of plaintiffs’ motion for class certification and ultimate resolution of an antitrust suit involving the wages paid to hospital nurses*
  • MassMutual in its sale of Oppenheimer Funds to Invesco*
  • Oaktree Capital in its sale of a majority interest to Brookfield Asset Management*
  • Maple Leaf Foods in its acquisition of Field Roast Grain Meat Company*
  • Avianca in its joint venture with United Airlines*
  • Rolls-Royce Holdings plc in its acquisition of the Industria de Turbo Propulsores SA, a leading aerospace component manufacturer*
  • Siliconware Precision Industries Co., Ltd., in the FTC approval of its merger with Taiwanese competitor Advanced Semiconductor Engineering, Inc.*
  • Holcim in obtaining FTC clearance of its merger with Lafarge*
  • Office Depot in its proposed merger with Staples*
  • and in obtaining dismissal of antitrust class action claims involving the online travel industry*

*Denotes experience prior to joining Goodwin.

Professional Experience

Prior to joining Goodwin, Mr. Lacy was a partner at Simpson Thacher & Bartlett where he helped found the firm’s Washington, D.C. office.

While in law school, Mr. Lacy served as Managing Editor of the Journal on Law and Policy in International Business.


Mr. Lacy is recognized by The Legal 500 U.S. and as a “Litigation Star” by Benchmark Litigation. He was previously also a core member of the group recognized as the Antitrust Department of the Year by Chambers USA 2016 and the Antitrust Litigation Department of the Year by The American Lawyer 2014.

In The News









J.D., 2002
Georgetown University Law Center
B.A., Economics and International Studies, 1997
American University



District of Columbia
New York


U.S. District Court for the Eastern District of New York
U.S. District Court for the Southern District of New York
U.S. District Court for the District of Columbia
U.S. Court of Appeals for the District of Columbia Circuit
U.S. Court of Appeals for the Second Circuit
U.S. Supreme Court
U.S. Court of Appeals for the Fourth Circuit
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique